GLP-1s and Addiction The authors of GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer , appearing in October 2025 in JES, point out that the World Health Organization reported 890 million adults and 60 million children and adolescents had obesity in 2022 globally
In addition, the ADAs current retinopathy standards acknowledge that GLP-1 receptor agonists have been associated with a risk of mildly worsening retinopathy in randomized trials
The Wolverine Blend medication program is $439 for a typical 46 week program and may include medication, syringes, alcohol pads, dosing instructions, and shipping when prescribed
The quantities in the feeding table are meant as a rough guide
Full batch traceability is provided for individual and bulk purchases, with US-based support and free Priority shipping on orders over $200